摘要
目的:观察痛泻要方治疗肝郁脾虚型肠易激综合征(腹泻型Diarrhea-predominantirritablebowelsyndrome,IBS-D)的临床疗效;方法:将60例患者随机分为2组即治疗组(30例)和对照组(30例),治疗组给予痛泻要方煎剂口服治疗,对照组给予匹维溴铵片口服。治疗一月后观察2组主要症状积分以及临床疗效;结果:治疗组总有效率86.7%,对照组67.7%,治疗组疗效优于对照组(P<0.05);结论:痛泻要方能够明显改善肝郁脾虚型IBS-D腹痛、腹泻、胸胁胀闷、精神状态以及饮食情况,有较好的临床疗效。
Objective：Clinical observation on the treatment of irritable bowel syndrome （ diarrhea type ） with stagna- tion of liver qi and spleen deficiency type;Method： 60 cases of patients were randomly divided into treatment group 30 cases and control group 30 cases, treatment group was given TCM Tongxieyaofang oral decoction treatment, the control group was given 50 rag/oral tablets, Pinaverium Bromide Tablets, one at a time, three times a day. After treatment, the main symptom scores and clinical efficacy of the two groups were observed;Results： The total effective rate of the treatment group was 86.7%, and that of the control group was 67.7%, and the curative effect of the treatment group was better than that of the control group （ P〈0.05 ） ; Conclusion： The prescription of pain reduction therapy can obviously improve the liver qi, spleen deficiency, IBS-D, abdominal pain, diarrhea, chest and rib distention, depression, mental state and diet, and have better clinical efficacy.
出处
《中医药临床杂志》
2017年第8期1310-1312,共3页
Clinical Journal of Traditional Chinese Medicine
关键词
肝郁脾虚
肠易激综合征
痛泻要方
腹泻
Liver stagnation and spleen deficiency
Irritable bowel syndrome
tongxieyao formula, diarrhea
